This IS a very important paper, pivalde, and anyone who skipped over it lightly before, should take some time to assimilate what is said here. Thanks.
Gotta love this:
"In preliminary (unpublished) studies using this 3D neural culture model of AD, PBT2 was observed to significantly reduce levels of detergent-resistant (TBS-insoluble) phospho-tau (relative to total tau), and to significantly increase neuronal cell viability..."
Mine too, kad.
Uncle Warren always says there's nothing like cash and courage in a crisis. Even though this is not anything like a crisis, I'll still be taking advantage of the situation by buying whenever I can. GLTA longs.
Yes, stan, you have it right.
Uncle Warren always says there's nothing like cash and courage in a crisis. Even though this isn't really anything like a crisis, I'll be taking advantage of the situation by buying more as I can. GLTA longs.
"The findings support further investigation of altered copper metabolism as a biomarker for early diagnosis of Alzheimer’s disease with PET/CT using 64CuCl2..."
The drum beat continues. Thanks, itm.
Norris, is there room for both Trovagene and Illumina's new interest, (mentioned in today's
press release) Urology Diagnostics Inc?
"Urology Diagnostics Incorporated is a genomics company from Oregon developing noninvasive urine sequencing diagnostics for screening and monitoring cancer."
Like this part especially:
"recent advances in analytical technology will allow detailed investigation of metalloproteins. Investigation of individual metalloproteins will yield new mechanistic details about the role of metals in AD"